Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: Cell surface targets
Bugelski PJ, Martin PL: Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets. Br J Pharmacol 2012; 166(3): 823-46
Infliximab in the treatment of anti-CTLA4 antibody (Ipilimumab) induced immune-Related colitis
Minor D, Chin K, Kashani-Sabet M: Infliximab in the treatment of anti-CTLA4 antibody (Ipilimumab) induced immune-related colitis. Cancer Biother Radiopharm 2009; 24(3): 321-25.
Enetrocolitis in a patient being treated with ipilimumab for metastatic melanoma
Koch Ch, Paetzold S, Trojan J: Enetrocolitis in a patient being treated with ipilimumab for metastatic melanoma. Gastroenterology 2012; 143(2): 298, 504-05.
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-Lymphocyte-Associated antigen 4
DOI 10.1200/JCO.2005.04.5716
Beck KE, Blanfield JA, Tran KQ et al.: Enerocolitis in patiens with cancer after anibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J ClinOncol 2006; 24(15): 2283-89 (Pubitemid 46630658)